Related Experiment Video
Updated: Jul 13, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
[Expression and Clinical Significance of Eukaryotic Initiation Factor 4E in Newly Diagnosed Patients with Multiple
Jin Quan Hong1, Yi Hui He2, Jian Xin Huang3
1Department of Anesthesia, The Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, Fujian Province, China.
Objective:
To explore the expression and clinical significance of eukaryotic translation initiation factor 4E(eIF4E) in bone marrow samples of newly diagnosed multiple myeloma (NDMM) patients.
Methods:
Immunohistochemical staining was used to analyze the expression of eIF4E protein in bone marrow biopsy samples from 75 NDMM patients and 25 patients with benign bone marrow disease. Clinical data were collected to analyze the correlation between eIF4E protein expression and clinical features and its prognostic significance in bone marrow samples of NDMM patients.
Results:
The positive rate of eIF4E protein expression in bone marrow samples of NDMM patients was higher than that in patients with benign bone marrow disease (P<0.001). Positive expression of eIF4E protein was correlated with elevated serum lactate dehydrogenase in MM patients. Univariate and multivariate analysis showed that positive expression of eIF4E protein was significantly associated with shortened overall survival (OS) in NDMM patients, and was an independent risk factor affecting OS in NDMM patients.
Conclusion:
Positive expression of eIF4E protein is an independent poor prognostic factor for OS in NDMM patients.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Mitogens and the Cell Cycle
Types of Intermediate Filaments
Differentiation of Common Myeloid Progenitor Cells

